sulthiame (sultiam)

01/01/2008 - "All children continued receiving sulthiame monotherapy (dose range, 8.0-9.3 mg/kg per day) for the study period without further seizures. "
04/01/2003 - "The effect of Sulthiame on the EEG and on clinical seizures was evaluated in an open uncontrolled study in 25 children with focal sharp waves on the EEG (FSW). "
01/01/2022 - "The clonic seizures recurred at age 4 years when sulthiame supply was interrupted, but the seizures promptly remitted following sulthiame's resumption. "
01/01/2022 - "After 2 weeks of sulthiame, seizures ceased completely. "
01/01/2019 - "For complete cessation of seizures during a nine-day follow-up period for add-on sulthiame versus placebo, the RR was 11.14 (95% CI 0.67 to 184.47; very low-certainty evidence), however, this difference was not shown to be statistically significant (P = 0.09). "

02/01/1993 - "An 18-year-old female patient with a particular form of intractable motor cortex epilepsy, in which motor partial seizure status occurred only during sleep every night, was reported focusing on the drastic efficacy of sulthiame on the seizure status. "
01/01/2019 - "Randomised controlled trials of add-on sulthiame, with any level of blinding (single, double or unblinded) in people of any age, with epilepsy of any aetiology. "
10/28/2015 - "Randomised controlled add-on trials of sulthiame in people of any age with epilepsy of any aetiology. "
03/28/2013 - "Randomised placebo-controlled add-on trials of sulthiame in people of any age with epilepsy of any aetiology. "
10/01/2004 - "The aim of the present study was to evaluate the efficacy and tolerability of sulthiame in childhood epilepsy by conducting a multicenter, retrospective study of patients who received this drug. "

09/05/2014 - "There is evidence from one trial reviewed that sulthiame is effective for seizure remission in the short term in children with BECTS although the precision of the effect estimate is uncertain due to its small sample size. "
01/01/2005 - "Thirty-nine children with BECTS from our department (aged 3-11 years) were analyzed as candidates to be enrolled in a prospective multicenter randomized double-blind placebo controlled study on therapeutic efficacy of sulthiame. "
01/01/2008 - "The purpose of this study was to determine if reduction in spike frequency in children with benign epilepsy of childhood with centrotemporal spikes treated with sulthiame correlates with improved neuropsychologic function. "
02/01/1999 - "A previously unpublished side effect of sulthiame in a patient with Rolandic epilepsy."
02/01/2003 - "The influence of sulthiame on EEG in children with benign childhood epilepsy with centrotemporal spikes (BECTS)."

02/01/2004 - "Sulthiame (STM), which is commonly used in some countries in the treatment of benign focal epilepsies in childhood, has been suggested to be effective in WS too. "
01/01/2023 - "This retrospective study aimed to evaluate the efficacy and tolerability of sulthiame (STM) as an add-on treatment in 49 patients with non-self-limited focal epilepsies of childhood (non-SeLFE) resistant to other antiseizure medications (ASM) and/or non-pharmacological treatment. "
12/01/1996 - "Sulthiame is effectively used in the treatment of benign and symptomatic focal epilepsy in children. "
10/01/1988 - "Benign partial epilepsy--treatment with sulthiame."
01/01/2023 - "Use of sulthiame as add-on therapy in children with non-self-limited focal epilepsies of childhood."

01/01/2006 - "Recently, 21 patients without epilepsy but with attention deficit and hyperactivity and/or learning disorders were studied: an open treatment trial with sulthiame resulted in improved sustained and selective attention. "
08/01/2002 - "This prospective uncontrolled open study explored the efficacy and long-term tolerability of sulthiame (STM) in 52 patients with refractory epilepsy and learning disability. "
08/01/2002 - "Sulthiame in adults with refractory epilepsy and learning disability: an open trial."